Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Endometrioid | 3 | 2021 | 290 | 0.970 |
Why?
|
Genital Neoplasms, Female | 4 | 2022 | 517 | 0.880 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2019 | 194 | 0.630 |
Why?
|
Endometrial Neoplasms | 3 | 2021 | 1343 | 0.630 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2021 | 671 | 0.610 |
Why?
|
Ovarian Neoplasms | 7 | 2022 | 4751 | 0.600 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2019 | 624 | 0.550 |
Why?
|
Precancerous Conditions | 1 | 2021 | 946 | 0.520 |
Why?
|
Gender Identity | 1 | 2018 | 567 | 0.470 |
Why?
|
Healthcare Disparities | 2 | 2018 | 3038 | 0.460 |
Why?
|
Lymph Nodes | 1 | 2021 | 3422 | 0.370 |
Why?
|
Sexual Behavior | 1 | 2018 | 1923 | 0.340 |
Why?
|
Telemedicine | 1 | 2021 | 2608 | 0.260 |
Why?
|
Hysterectomy | 4 | 2022 | 905 | 0.240 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2020 | 8896 | 0.230 |
Why?
|
Endometrial Hyperplasia | 1 | 2021 | 90 | 0.200 |
Why?
|
Lymph Node Excision | 3 | 2021 | 1192 | 0.200 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2023 | 1974 | 0.200 |
Why?
|
Genetic Counseling | 2 | 2020 | 578 | 0.180 |
Why?
|
DNA Glycosylases | 1 | 2019 | 134 | 0.170 |
Why?
|
Perimenopause | 1 | 2019 | 132 | 0.170 |
Why?
|
Vulvar Neoplasms | 1 | 2020 | 292 | 0.160 |
Why?
|
CA-125 Antigen | 1 | 2019 | 279 | 0.160 |
Why?
|
Serine Endopeptidases | 1 | 2021 | 1079 | 0.150 |
Why?
|
Genes, BRCA2 | 1 | 2019 | 592 | 0.150 |
Why?
|
Carcinoma in Situ | 1 | 2021 | 823 | 0.140 |
Why?
|
Fetal Blood | 1 | 2021 | 1324 | 0.130 |
Why?
|
Neoplasm Staging | 5 | 2022 | 11145 | 0.130 |
Why?
|
Neoplasm, Residual | 1 | 2019 | 986 | 0.130 |
Why?
|
Prenatal Care | 1 | 2021 | 1040 | 0.130 |
Why?
|
SEER Program | 1 | 2018 | 1572 | 0.120 |
Why?
|
Neoadjuvant Therapy | 2 | 2021 | 2556 | 0.120 |
Why?
|
Placenta | 1 | 2021 | 1538 | 0.120 |
Why?
|
Professional-Patient Relations | 1 | 2018 | 736 | 0.110 |
Why?
|
Female | 19 | 2023 | 377334 | 0.110 |
Why?
|
Psychometrics | 1 | 2021 | 2970 | 0.110 |
Why?
|
Neoplasm Invasiveness | 1 | 2019 | 3681 | 0.100 |
Why?
|
Laparoscopy | 1 | 2022 | 1980 | 0.100 |
Why?
|
Postmenopause | 1 | 2019 | 2419 | 0.100 |
Why?
|
Genetic Testing | 2 | 2020 | 3351 | 0.100 |
Why?
|
Middle Aged | 10 | 2021 | 214757 | 0.080 |
Why?
|
Retrospective Studies | 9 | 2022 | 72458 | 0.080 |
Why?
|
Aged | 10 | 2021 | 162518 | 0.080 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2021 | 3551 | 0.080 |
Why?
|
Sex Factors | 1 | 2021 | 10672 | 0.080 |
Why?
|
Humans | 19 | 2023 | 715914 | 0.080 |
Why?
|
Pregnancy | 3 | 2023 | 27399 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2019 | 3451 | 0.070 |
Why?
|
Disease-Free Survival | 3 | 2022 | 7014 | 0.070 |
Why?
|
Colposcopy | 1 | 2023 | 144 | 0.060 |
Why?
|
Lymphatic Metastasis | 2 | 2020 | 2967 | 0.050 |
Why?
|
Adult | 6 | 2021 | 212329 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 7311 | 0.050 |
Why?
|
Postoperative Complications | 2 | 2021 | 15080 | 0.050 |
Why?
|
Prisons | 1 | 2023 | 149 | 0.050 |
Why?
|
Infusions, Parenteral | 1 | 2021 | 428 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11236 | 0.050 |
Why?
|
Virginia | 1 | 2019 | 124 | 0.050 |
Why?
|
Mutation | 2 | 2020 | 29301 | 0.040 |
Why?
|
Obesity | 1 | 2020 | 12253 | 0.040 |
Why?
|
Ovary | 1 | 2020 | 1000 | 0.040 |
Why?
|
Mass Screening | 2 | 2023 | 5210 | 0.030 |
Why?
|
Young Adult | 2 | 2020 | 56230 | 0.030 |
Why?
|
Risk Factors | 2 | 2020 | 70927 | 0.030 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2021 | 1323 | 0.030 |
Why?
|
Fetus | 1 | 2021 | 1853 | 0.030 |
Why?
|
Family Health | 1 | 2019 | 1290 | 0.030 |
Why?
|
Adolescent | 2 | 2020 | 85155 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2020 | 20063 | 0.030 |
Why?
|
Advance Care Planning | 1 | 2020 | 616 | 0.030 |
Why?
|
Prospective Studies | 3 | 2022 | 51362 | 0.030 |
Why?
|
Brachytherapy | 1 | 2020 | 1282 | 0.030 |
Why?
|
Child | 1 | 2018 | 74460 | 0.020 |
Why?
|
Quality of Life | 2 | 2022 | 11722 | 0.020 |
Why?
|
Reoperation | 1 | 2020 | 4169 | 0.020 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2021 | 2034 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2023 | 2939 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2020 | 5075 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8744 | 0.020 |
Why?
|
Gene Expression | 1 | 2021 | 7954 | 0.020 |
Why?
|
Cohort Studies | 2 | 2022 | 40050 | 0.020 |
Why?
|
Length of Stay | 1 | 2021 | 6268 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10500 | 0.020 |
Why?
|
Patient Readmission | 1 | 2020 | 2980 | 0.020 |
Why?
|
Communication | 1 | 2020 | 3518 | 0.020 |
Why?
|
Quality Improvement | 1 | 2021 | 3741 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2021 | 58328 | 0.020 |
Why?
|
Palliative Care | 1 | 2020 | 3286 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2019 | 12490 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 13208 | 0.020 |
Why?
|
Logistic Models | 1 | 2019 | 13630 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5039 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18796 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2023 | 39320 | 0.010 |
Why?
|
Risk Assessment | 1 | 2021 | 23485 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17416 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 40903 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 62019 | 0.010 |
Why?
|
Male | 1 | 2021 | 350411 | 0.000 |
Why?
|
Concepts
(99)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(40)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_